Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.

The global Cell and Gene Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Cell and Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cell and Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cell and Gene Therapy include Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG and Orchard Therapeutics plc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy.

Report Scope

The Cell and Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell and Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell and Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cell and Gene Therapy Market Report

Report Metric	Details
Report Name	Cell and Gene Therapy Market
Segment by Type	Rare Diseases Oncology Hematology Cardiovascular Ophthalmology Neurology Other Therapeutic Classes
Segment by Application	Pharmaceutical and Biotechnology Companies Research and Academic Institutions Contract Research Organizations (CROs) Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co., Ltd.,, Sibiono GeneTech Co. Ltd.,, Spark Therapeutics, Inc., Vericel Corporation, ViroMed Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Market report?

Ans: The main players in the Cell and Gene Therapy Market are Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co., Ltd.,, Sibiono GeneTech Co. Ltd.,, Spark Therapeutics, Inc., Vericel Corporation, ViroMed Co., Ltd.

What are the Application segmentation covered in the Cell and Gene Therapy Market report?

Ans: The Applications covered in the Cell and Gene Therapy Market report are Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Hospital, Others

What are the Type segmentation covered in the Cell and Gene Therapy Market report?

Ans: The Types covered in the Cell and Gene Therapy Market report are Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology, Other Therapeutic Classes

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Rare Diseases

1.2.3 Oncology

1.2.4 Hematology

1.2.5 Cardiovascular

1.2.6 Ophthalmology

1.2.7 Neurology

1.2.8 Other Therapeutic Classes

1.3 Market by Application

1.3.1 Global Cell and Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research and Academic Institutions

1.3.4 Contract Research Organizations (CROs)

1.3.5 Hospital

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell and Gene Therapy Market Perspective (2019-2030)

2.2 Cell and Gene Therapy Growth Trends by Region

2.2.1 Global Cell and Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cell and Gene Therapy Historic Market Size by Region (2019-2024)

2.2.3 Cell and Gene Therapy Forecasted Market Size by Region (2025-2030)

2.3 Cell and Gene Therapy Market Dynamics

2.3.1 Cell and Gene Therapy Industry Trends

2.3.2 Cell and Gene Therapy Market Drivers

2.3.3 Cell and Gene Therapy Market Challenges

2.3.4 Cell and Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell and Gene Therapy Players by Revenue

3.1.1 Global Top Cell and Gene Therapy Players by Revenue (2019-2024)

3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell and Gene Therapy Revenue

3.4 Global Cell and Gene Therapy Market Concentration Ratio

3.4.1 Global Cell and Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Revenue in 2023

3.5 Cell and Gene Therapy Key Players Head office and Area Served

3.6 Key Players Cell and Gene Therapy Product Solution and Service

3.7 Date of Enter into Cell and Gene Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Breakdown Data by Type

4.1 Global Cell and Gene Therapy Historic Market Size by Type (2019-2024)

4.2 Global Cell and Gene Therapy Forecasted Market Size by Type (2025-2030)

5 Cell and Gene Therapy Breakdown Data by Application

5.1 Global Cell and Gene Therapy Historic Market Size by Application (2019-2024)

5.2 Global Cell and Gene Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cell and Gene Therapy Market Size (2019-2030)

6.2 North America Cell and Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cell and Gene Therapy Market Size by Country (2019-2024)

6.4 North America Cell and Gene Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell and Gene Therapy Market Size (2019-2030)

7.2 Europe Cell and Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cell and Gene Therapy Market Size by Country (2019-2024)

7.4 Europe Cell and Gene Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cell and Gene Therapy Market Size (2019-2030)

8.2 Asia-Pacific Cell and Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Cell and Gene Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cell and Gene Therapy Market Size (2019-2030)

9.2 Latin America Cell and Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cell and Gene Therapy Market Size by Country (2019-2024)

9.4 Latin America Cell and Gene Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell and Gene Therapy Market Size (2019-2030)

10.2 Middle East & Africa Cell and Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Cell and Gene Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen Inc.

11.1.1 Amgen Inc. Company Detail

11.1.2 Amgen Inc. Business Overview

11.1.3 Amgen Inc. Cell and Gene Therapy Introduction

11.1.4 Amgen Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.1.5 Amgen Inc. Recent Development

11.2 bluebird bio, Inc.

11.2.1 bluebird bio, Inc. Company Detail

11.2.2 bluebird bio, Inc. Business Overview

11.2.3 bluebird bio, Inc. Cell and Gene Therapy Introduction

11.2.4 bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.2.5 bluebird bio, Inc. Recent Development

11.3 Dendreon Pharmaceuticals LLC.

11.3.1 Dendreon Pharmaceuticals LLC. Company Detail

11.3.2 Dendreon Pharmaceuticals LLC. Business Overview

11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Introduction

11.3.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2019-2024)

11.3.5 Dendreon Pharmaceuticals LLC. Recent Development

11.4 Fibrocell Science, Inc.

11.4.1 Fibrocell Science, Inc. Company Detail

11.4.2 Fibrocell Science, Inc. Business Overview

11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Introduction

11.4.4 Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.4.5 Fibrocell Science, Inc. Recent Development

11.5 Human Stem Cells Institute

11.5.1 Human Stem Cells Institute Company Detail

11.5.2 Human Stem Cells Institute Business Overview

11.5.3 Human Stem Cells Institute Cell and Gene Therapy Introduction

11.5.4 Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2019-2024)

11.5.5 Human Stem Cells Institute Recent Development

11.6 Kite Pharma, Inc.

11.6.1 Kite Pharma, Inc. Company Detail

11.6.2 Kite Pharma, Inc. Business Overview

11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Introduction

11.6.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.6.5 Kite Pharma, Inc. Recent Development

11.7 Kolon TissueGene, Inc.

11.7.1 Kolon TissueGene, Inc. Company Detail

11.7.2 Kolon TissueGene, Inc. Business Overview

11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Introduction

11.7.4 Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.7.5 Kolon TissueGene, Inc. Recent Development

11.8 Novartis AG

11.8.1 Novartis AG Company Detail

11.8.2 Novartis AG Business Overview

11.8.3 Novartis AG Cell and Gene Therapy Introduction

11.8.4 Novartis AG Revenue in Cell and Gene Therapy Business (2019-2024)

11.8.5 Novartis AG Recent Development

11.9 Orchard Therapeutics plc.

11.9.1 Orchard Therapeutics plc. Company Detail

11.9.2 Orchard Therapeutics plc. Business Overview

11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Introduction

11.9.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.9.5 Orchard Therapeutics plc. Recent Development

11.10 Organogenesis Holdings Inc.

11.10.1 Organogenesis Holdings Inc. Company Detail

11.10.2 Organogenesis Holdings Inc. Business Overview

11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Introduction

11.10.4 Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.10.5 Organogenesis Holdings Inc. Recent Development

11.11 Pfizer, Inc.

11.11.1 Pfizer, Inc. Company Detail

11.11.2 Pfizer, Inc. Business Overview

11.11.3 Pfizer, Inc. Cell and Gene Therapy Introduction

11.11.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.11.5 Pfizer, Inc. Recent Development

11.12 RENOVA THERAPEUTICS

11.12.1 RENOVA THERAPEUTICS Company Detail

11.12.2 RENOVA THERAPEUTICS Business Overview

11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Introduction

11.12.4 RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2019-2024)

11.12.5 RENOVA THERAPEUTICS Recent Development

11.13 Shanghai Sunway Biotech Co., Ltd.,

11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Detail

11.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview

11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Introduction

11.13.4 Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2019-2024)

11.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Development

11.14 Sibiono GeneTech Co. Ltd.,

11.14.1 Sibiono GeneTech Co. Ltd., Company Detail

11.14.2 Sibiono GeneTech Co. Ltd., Business Overview

11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Introduction

11.14.4 Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2019-2024)

11.14.5 Sibiono GeneTech Co. Ltd., Recent Development

11.15 Spark Therapeutics, Inc.

11.15.1 Spark Therapeutics, Inc. Company Detail

11.15.2 Spark Therapeutics, Inc. Business Overview

11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Introduction

11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2019-2024)

11.15.5 Spark Therapeutics, Inc. Recent Development

11.16 Vericel Corporation

11.16.1 Vericel Corporation Company Detail

11.16.2 Vericel Corporation Business Overview

11.16.3 Vericel Corporation Cell and Gene Therapy Introduction

11.16.4 Vericel Corporation Revenue in Cell and Gene Therapy Business (2019-2024)

11.16.5 Vericel Corporation Recent Development

11.17 ViroMed Co., Ltd.

11.17.1 ViroMed Co., Ltd. Company Detail

11.17.2 ViroMed Co., Ltd. Business Overview

11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Introduction

11.17.4 ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2019-2024)

11.17.5 ViroMed Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amgen Inc

bluebird bio Inc

Dendreon Pharmaceuticals LLC.

Fibrocell Science, Inc.

Human Stem Cells Institute

Kite Pharma Inc.

Kolon TissueGene, Inc.

Novartis

Orchard Therapeutics plc.

Organogenesis Holdings Inc.

Pfizer Inc

RENOVA THERAPEUTICS

Shanghai Sunway Biotech Co., Ltd.,

Sibiono GeneTech Co. Ltd.,

Spark Therapeutics Inc

Vericel Corporation

ViroMed

List of Tables

Table 1. Global Cell and Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Rare Diseases

Table 3. Key Players of Oncology

Table 4. Key Players of Hematology

Table 5. Key Players of Cardiovascular

Table 6. Key Players of Ophthalmology

Table 7. Key Players of Neurology

Table 8. Key Players of Other Therapeutic Classes

Table 9. Global Cell and Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Cell and Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Cell and Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Cell and Gene Therapy Market Share by Region (2019-2024)

Table 13. Global Cell and Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Cell and Gene Therapy Market Share by Region (2025-2030)

Table 15. Cell and Gene Therapy Market Trends

Table 16. Cell and Gene Therapy Market Drivers

Table 17. Cell and Gene Therapy Market Challenges

Table 18. Cell and Gene Therapy Market Restraints

Table 19. Global Cell and Gene Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Cell and Gene Therapy Market Share by Players (2019-2024)

Table 21. Global Top Cell and Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy as of 2023)

Table 22. Ranking of Global Top Cell and Gene Therapy Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Cell and Gene Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Cell and Gene Therapy Product Solution and Service

Table 26. Date of Enter into Cell and Gene Therapy Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Cell and Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Cell and Gene Therapy Revenue Market Share by Type (2019-2024)

Table 30. Global Cell and Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Cell and Gene Therapy Revenue Market Share by Type (2025-2030)

Table 32. Global Cell and Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Cell and Gene Therapy Revenue Market Share by Application (2019-2024)

Table 34. Global Cell and Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Cell and Gene Therapy Revenue Market Share by Application (2025-2030)

Table 36. North America Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Cell and Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Cell and Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Cell and Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Cell and Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Cell and Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Cell and Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Cell and Gene Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Cell and Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Cell and Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Cell and Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Cell and Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 51. Amgen Inc. Company Detail

Table 52. Amgen Inc. Business Overview

Table 53. Amgen Inc. Cell and Gene Therapy Product

Table 54. Amgen Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 55. Amgen Inc. Recent Development

Table 56. bluebird bio, Inc. Company Detail

Table 57. bluebird bio, Inc. Business Overview

Table 58. bluebird bio, Inc. Cell and Gene Therapy Product

Table 59. bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 60. bluebird bio, Inc. Recent Development

Table 61. Dendreon Pharmaceuticals LLC. Company Detail

Table 62. Dendreon Pharmaceuticals LLC. Business Overview

Table 63. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product

Table 64. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 65. Dendreon Pharmaceuticals LLC. Recent Development

Table 66. Fibrocell Science, Inc. Company Detail

Table 67. Fibrocell Science, Inc. Business Overview

Table 68. Fibrocell Science, Inc. Cell and Gene Therapy Product

Table 69. Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 70. Fibrocell Science, Inc. Recent Development

Table 71. Human Stem Cells Institute Company Detail

Table 72. Human Stem Cells Institute Business Overview

Table 73. Human Stem Cells Institute Cell and Gene Therapy Product

Table 74. Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 75. Human Stem Cells Institute Recent Development

Table 76. Kite Pharma, Inc. Company Detail

Table 77. Kite Pharma, Inc. Business Overview

Table 78. Kite Pharma, Inc. Cell and Gene Therapy Product

Table 79. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 80. Kite Pharma, Inc. Recent Development

Table 81. Kolon TissueGene, Inc. Company Detail

Table 82. Kolon TissueGene, Inc. Business Overview

Table 83. Kolon TissueGene, Inc. Cell and Gene Therapy Product

Table 84. Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 85. Kolon TissueGene, Inc. Recent Development

Table 86. Novartis AG Company Detail

Table 87. Novartis AG Business Overview

Table 88. Novartis AG Cell and Gene Therapy Product

Table 89. Novartis AG Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 90. Novartis AG Recent Development

Table 91. Orchard Therapeutics plc. Company Detail

Table 92. Orchard Therapeutics plc. Business Overview

Table 93. Orchard Therapeutics plc. Cell and Gene Therapy Product

Table 94. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 95. Orchard Therapeutics plc. Recent Development

Table 96. Organogenesis Holdings Inc. Company Detail

Table 97. Organogenesis Holdings Inc. Business Overview

Table 98. Organogenesis Holdings Inc. Cell and Gene Therapy Product

Table 99. Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 100. Organogenesis Holdings Inc. Recent Development

Table 101. Pfizer, Inc. Company Detail

Table 102. Pfizer, Inc. Business Overview

Table 103. Pfizer, Inc. Cell and Gene Therapy Product

Table 104. Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 105. Pfizer, Inc. Recent Development

Table 106. RENOVA THERAPEUTICS Company Detail

Table 107. RENOVA THERAPEUTICS Business Overview

Table 108. RENOVA THERAPEUTICS Cell and Gene Therapy Product

Table 109. RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 110. RENOVA THERAPEUTICS Recent Development

Table 111. Shanghai Sunway Biotech Co., Ltd., Company Detail

Table 112. Shanghai Sunway Biotech Co., Ltd., Business Overview

Table 113. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product

Table 114. Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 115. Shanghai Sunway Biotech Co., Ltd., Recent Development

Table 116. Sibiono GeneTech Co. Ltd., Company Detail

Table 117. Sibiono GeneTech Co. Ltd., Business Overview

Table 118. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product

Table 119. Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 120. Sibiono GeneTech Co. Ltd., Recent Development

Table 121. Spark Therapeutics, Inc. Company Detail

Table 122. Spark Therapeutics, Inc. Business Overview

Table 123. Spark Therapeutics, Inc. Cell and Gene Therapy Product

Table 124. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 125. Spark Therapeutics, Inc. Recent Development

Table 126. Vericel Corporation Company Detail

Table 127. Vericel Corporation Business Overview

Table 128. Vericel Corporation Cell and Gene Therapy Product

Table 129. Vericel Corporation Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 130. Vericel Corporation Recent Development

Table 131. ViroMed Co., Ltd. Company Detail

Table 132. ViroMed Co., Ltd. Business Overview

Table 133. ViroMed Co., Ltd. Cell and Gene Therapy Product

Table 134. ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2019-2024) & (US$ Million)

Table 135. ViroMed Co., Ltd. Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cell and Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cell and Gene Therapy Market Share by Type: 2023 VS 2030

Figure 3. Rare Diseases Features

Figure 4. Oncology Features

Figure 5. Hematology Features

Figure 6. Cardiovascular Features

Figure 7. Ophthalmology Features

Figure 8. Neurology Features

Figure 9. Other Therapeutic Classes Features

Figure 10. Global Cell and Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Cell and Gene Therapy Market Share by Application: 2023 VS 2030

Figure 12. Pharmaceutical and Biotechnology Companies Case Studies

Figure 13. Research and Academic Institutions Case Studies

Figure 14. Contract Research Organizations (CROs) Case Studies

Figure 15. Hospital Case Studies

Figure 16. Others Case Studies

Figure 17. Cell and Gene Therapy Report Years Considered

Figure 18. Global Cell and Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Cell and Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Cell and Gene Therapy Market Share by Region: 2023 VS 2030

Figure 21. Global Cell and Gene Therapy Market Share by Players in 2023

Figure 22. Global Top Cell and Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Revenue in 2023

Figure 24. North America Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Cell and Gene Therapy Market Share by Country (2019-2030)

Figure 26. United States Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Cell and Gene Therapy Market Share by Country (2019-2030)

Figure 30. Germany Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Cell and Gene Therapy Market Share by Region (2019-2030)

Figure 38. China Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Cell and Gene Therapy Market Share by Country (2019-2030)

Figure 46. Mexico Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Cell and Gene Therapy Market Share by Country (2019-2030)

Figure 50. Turkey Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Cell and Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Amgen Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 53. bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 54. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 55. Fibrocell Science, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 56. Human Stem Cells Institute Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 57. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 58. Kolon TissueGene, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 59. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 60. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 61. Organogenesis Holdings Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 62. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 63. RENOVA THERAPEUTICS Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 64. Shanghai Sunway Biotech Co., Ltd., Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 65. Sibiono GeneTech Co. Ltd., Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 66. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 67. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 68. ViroMed Co., Ltd. Revenue Growth Rate in Cell and Gene Therapy Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions